Popular in Science
- Archived Episodes (8)
-
Part 1: Close Up Radio Spotlights Samuel Gibson of Hadron Energy
in Energy
San Francisco, CA – Samuel Gibson is the founder and CEO of Hadron Energy, a nuclear engineering company. Currently, his company is building the patent pending Micro-Modular Reactor.
The Micro-Modular Reactor (MMR) is a two-megawatt microreactor that utilizes nuclear fission to generate electricity. Using low-enriched uranium as its fuel source, the power for each MMR is designed to last ten years, before it needs to be replaced.
“Overall, MMR technology is compact, mobile, safe, and secure,” notes Samuel. “One MMR unit can power two thousand homes and multiple units can be stacked up to meet larger demand.”
“The majority of Americans now support nuclear energy as a viable source for the future,” he observes.
Sam identifies four different segments of customers that Hadron Energy seeks to reach. They include remote communities, data centers, government installations, and the industrial market.
“Ever since I could remember, I was always interested in engineering,” recalls Samuel.
Presently at age twenty-three, Samuel has the distinct honor of being the youngest professional ever featured on Close Up Radio.
By 2026, Samuel plans to have the first MMR available for end use. Along the way, as there is a significant demand for this technology, he seeks to expand through customers, partnerships, and investment. Currently, he has twelve team members on staff and looks to hire more.
“Our ultimate plan for the future is that it becomes a global operation,” he explains. “There is a need for this around the world. Our company will play a major part in this.”
For more information, please visit https://www.hadronenergy.com/
-
Close Up Radio Spotlights Pharmaceutical Consultant Dr. Jan Lundberg
in Medicine
Fort Lauderdale, FL - Dr. Jan Lundberg, a distinguished leader in the bio-pharmaceutical industry with over four decades of experience, has embarked on a new venture as a pharmaceutical consultant. With a career that seamlessly bridged academia and industry, Lundberg is offering his wealth of expertise to drive innovation in drug discovery and development. Based in Fort Lauderdale, Florida, Lundberg is poised to provide strategic guidance to biotech firms, pharmaceutical companies, and academic institutions aiming to tackle the world’s most pressing health challenges.
Born in Sweden, Jan Lundberg’s journey in the sciences began during his studies in America with chemistry and psychology at Gustavus Adolphus College, Minnesota. His fascination with medicine had taken root at a young age, inspired by his uncle, who showed Jan his blood under a microscope. This early curiosity set him on a path through academia, medicine, and into the heart of pharmaceutical innovation.
Lundberg’s consulting services focus on key areas such as diabetes, Alzheimer’s disease, autoimmune disorders, and cancer. He is keenly aware of the complexities involved in treating conditions like cancer, which demands personalized approaches through precision medicine. “Cancer encompasses hundreds, if not thousands, of diseases. Tailored therapies based on individual biomarkers such as genetic profiles are the future,” asserts Lundberg.
After retiring from Eli Lilly, Lundberg enjoys the sun-drenched lifestyle of Fort Lauderdale, mixed with outdoor activities in Jackson Hole, Wyoming yet maintains strong professional connections with both Sweden and the global scientific community.
For more information about Jan Lundberg, please visit https://www.linkedin.com/in/jan-m-lundberg-77729a95/
-
Practically Speaking: Cabozantinib – another treatment in the medicine CABINET
in Medicine
To be added to the distribution list, please email: DDeCastro@southlake.ca
In this episode of MedOncNow, Dr. Simron Singh discusses the use of Cabozantinib in the managment of Extra-Pancreatic and Pancreatic NETs. This is timely given we now have access to Cabozaninib through a company sponsored case by case access program for pretreated NETs patients.
Key Opinion Leader:
Simron Singh, MD, MPH, FRCPC Staff Medical Oncologist, Sunnybrook Health Sciences Centre Professor, University of Toronto Host: Shaqil Kassam MD. MSc. FRCPC skassam@southlake.ca Medical Oncologist Stronach Regional Cancer Centre, Newmarket, Ontario
Previous episodes: https://www.blogtalkradio.com/medoncnow
X- @medoncnow
-
Devin Blair Is On Air!
in Science
Chemical Rocketeers is a thrilling sci-fi podcast created by Devin Blair, set in a post-apocalyptic universe where humanity fights for survival and a new beginning on a distant, enigmatic planet. The story revolves around the Rocketeer's colony—a select group of survivors sent to Horizon Moon after a catastrophic nuclear event on Earth. Tasked with rebuilding human civilization, the colony faces relentless challenges, including alien creatures, hostile factions, and the remnants of Earth's ancient technology. Rooted in themes of exploration, resilience, and adventure, each episode weaves action-packed moments with immersive storytelling, inviting listeners into a world where survival isn’t just about living—it’s about thriving against all odds.
-
Why is Marlyland Income Eligibility Limits for Energy Bill Assistance So Low?
in Energy
Call-In# 646-668-2948 ---- EPISODE 392
Date: 11/27/2024 .... . Hosted By: Ronald Bethea
Host: Introduction: 11;:00 -11:03 am Est.: Introduction
Host: 11:04 am Est.: 11:34 am. Est. ; Topic of Discussion: Why is Marlyland Income Eligibility Limits for Energy Bill Assistance So Low?
Host: 11:35 am - 11:38 am Est.: Commerical
Host 11:39 - 11:57 am Est: Topic of discussion: Est.: Why Is My Electric Bill So Dawm High
Host: 11:58-12:00 pm Est.: Closing Remarks
-
truly are we thankful for what we have or really are.
when we say we thankful mean it from the heart . not becaue it soulds right.
-
Time Up
Join us as we talk about people who come to visit but stay a little longer that what was expected. So now the question is how do we tell them that it is time to go. Do you write them a note?